Results of Self-Sampling Methodology Impression for Cervical Cancer Screening in Mongolia.
Autor: | Tsedenbal B; Mongolian National University of Medical Sciences, Mongolia.; National Center for Pathology, Mongolia., Enebish G; Mongolian National University of Medical Sciences, Mongolia., Tserensodnom B; Mongolian National University of Medical Sciences, Mongolia., Saio M; Gunma University, Graduate School of Health Sciences, Japan. |
---|---|
Jazyk: | angličtina |
Zdroj: | Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2022 Dec 01; Vol. 23 (12), pp. 4099-4107. Date of Electronic Publication: 2022 Dec 01. |
DOI: | 10.31557/APJCP.2022.23.12.4099 |
Abstrakt: | Objective: Mongolia is a sparsely populated country; however, almost fifty percent of the population lives in the capital city. Medical care services and exceptionally well-organized cervical cancer screening tests are limited in remote areas. To improve cervical cancer screening test coverage, we compared the interest between physicians taking samples and self-sampling among the attendees in this study. Methods: A total of 175 women participated in this study. The hundred twelve women visited the Gynecology ward, and the sixty-three women were provided with the cervical self-sampling test kit and filled out a questionnaire. Subsequently, the acceptability of physician taking and self-sampling were evaluated using a questionnaire. All specimens were processed using the TACAS LBC system, and the quality of samples was tested by cytology. Results: Regarding the acceptability of self-sampling, the selections for subsequent screening were 36% self-sampling and 64% gynecologist-sampling methods. The acceptability rates were higher in the remote areas than the urban areas. However, 64% of the participants lacked knowledge that the causative agent of cervical cancer is the human papillomavirus, and 66.9% mainly were sexually transmitted. In addition, 82.3% of the women surveyed were unaware that there was a vaccine to prevent cervical cancer, but 88.6% wanted to be vaccinated. Of most women, 44.4% chose self-sampling due to no embarrassment in the gynecological examination. The self-sampling preferences were dominant in the old age group (61.6%). The cytology satisfaction rate in physician-sampling (99.1%) was higher than in the self-sampling group (69.8%). Conclusion: The Implementation of the self-sampling tool may be considered a primary screening. The self-sampling test can adopt into the early screening program and may increase the coverage of the screening program and improve the quality. |
Databáze: | MEDLINE |
Externí odkaz: |